Analyst Recommendations

Barclays analyst issues EQUAL-WEIGHT recommendation for KMB on April 12, 2024 05:11AM ET. The previous analyst recommendation was Equal-Weight.KMB was trading at $126.08 at issue of the analyst...

April 12, 2024   KMB -0.90%

Barclays analyst issues OVERWEIGHT recommendation for PEP on April 12, 2024 05:12AM ET. The previous analyst recommendation was Overweight.PEP was trading at $168.36 at issue of the analyst...

April 12, 2024   PEP -0.27%

Barclays analyst issues OVERWEIGHT recommendation for KO on April 12, 2024 05:13AM ET. The previous analyst recommendation was Overweight.KO was trading at $59.05 at issue of the analyst...

April 12, 2024   KO -0.91%

UBS analyst issues SECTOR PERFORM recommendation for PPG on April 9, 2024 08:00AM ET. The previous analyst recommendation was Sector Perform.PPG was trading at $139.91 at issue of...

April 9, 2024   PPG 0.57%

RBC Capital analyst issues UNDERPERFORM recommendation for PPG on April 9, 2024 08:00AM ET. The previous analyst recommendation was Underperform.PPG was trading at $139.91 at issue of the...

April 9, 2024   PPG 0.57%

Piper Sandler analyst issues OVERWEIGHT recommendation for KVUE on April 9, 2024 05:43AM ET. The previous analyst recommendation was Overweight.KVUE was trading at $20.06 at issue of the...

April 9, 2024   KVUE -0.46%

Wolfe Research analyst issues OUTPERFORM recommendation for EMR on April 8, 2024 02:00PM ET. The previous analyst recommendation was Outperform.EMR was trading at $114.89 at issue of the...

April 8, 2024   EMR -0.62%

Evercore ISI analyst issues OUTPERFORM recommendation for CL on April 8, 2024 08:27AM ET. The previous analyst recommendation was Outperform.CL was trading at $87.88 at issue of the...

April 8, 2024   CL -1.98%

Citigroup analyst issues NEUTRAL recommendation for MMM on April 8, 2024 07:27AM ET. The previous analyst recommendation was Neutral.MMM was trading at $91.03 at issue of the analyst...

April 8, 2024   MMM -0.12%

Citigroup analyst issues BUY recommendation for EMR on April 8, 2024 07:29AM ET. The previous analyst recommendation was Buy.EMR was trading at $114.54 at issue of the analyst...

April 8, 2024   EMR -0.62%